Complementation of Plasmodium berghei TRAP knockout parasites using human dihydrofolate reductase gene as a selectable marker

Ali Sultan, Vandana Thathy, Tania F. De Koning-Ward, Victor Nussenzweig

Research output: Contribution to journalArticle

17 Citations (Scopus)


Previously we have used the Plasmodium dihydrofolate reductase thymidylate synthase (DHFR-TS) selectable marker to generate Plasmodium berghei TRAP null mutant parasites. These TRAP null mutants do not glide and they showed a great reduction in their ability to infect mosquito salivary glands and the hepatocytes of the vertebrate host. Thus far, complementation of these knockout parasites was not possible due to the lack of additional selectable markers. Recently, a new selectable marker, based on the human dihydrofolate reductase (hDHFR) gene, has been developed which confers resistance to the antifolate drug WR99210. This drug has been found to be highly active against pyrimethamine-sensitive and -resistant strains of P. berghei. In this study, we have used the hDHFR gene as a second selectable marker for the complementation of P. berghei TRAP null mutant parasites. Restoration of the TRAP null mutant parasites to the wild-type phenotype was achieved in this study via autonomously replicating episomes bearing a wild-type copy of the TRAP gene. This is the first report of complementation of a mutant phenotype in malaria parasites.

Original languageEnglish
Pages (from-to)151-156
Number of pages6
JournalMolecular and Biochemical Parasitology
Issue number1
Publication statusPublished - 2001
Externally publishedYes



  • Genetic complementation
  • Human dihydrofolate reductase (hDHFR)
  • Plasmodium berghei
  • Thrombospondin-related anonymous protein (TRAP)

ASJC Scopus subject areas

  • Molecular Biology
  • Parasitology

Cite this